AROMASIN is indicated for adjuvant therapy of postmenopausal Gals with estrogen-receptor favourable early breast cancer who've acquired two to 3 years of tamoxifen and therefore are switched to AROMASIN for completion of a total of five consecutive a long time of adjuvant hormonal therapy [see Clinical Reports (fourteen.1)].Recommend females of rep